SEC Form 4 · accession 0001209191-16-088050
ARROWHEAD PHARMACEUTICALS, INC. · ARWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Brian Leone
Officer — VP, Strategy & Program Mgmt
Period of report
Jan 1, 2016
Accepted (ET)
Jan 4, 2016 · 7:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879407
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $6.15 | Jan 1, 2016 | A | 50,000 | A | — | Jan 1, 2026 | Common Stock | 50,000 | 220,000 | D |
Explanation of responses
- F1Option vests and becomes exercisable over a four year period from date of grant.